Evotec grants licence to Roche Diagnostics:
This article was originally published in Clinica
German company Evotec OAI has granted Roche Diagnostics a licence covering the melting curve analysis of investigated gene fragments in polymerase chain reactions (PCR). Hamburg-based Evotec says the use of its technology in instrumentation and kits increases the accuracy of data of diagnostic kits. Evotec will gain royalties on future product sales as well as milestone payments. Roche will apply the technology to its LightCycler technology.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.